Difference between revisions of "Gwak JM, et al. Oncotarget (2017) cited as Ref 79 in DOI: 10.1038/s41392-020-0110-5 (Q9342)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2017, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Fifth Author string (P153): Park SY, #quickstatements; #temporary_batch_1590155508986) |
||
| (5 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Oncotarget | ||
| Property / Published In Name String: Oncotarget / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 8 | ||
| Property / Volume: 8 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance (English) | ||
| Property / title: Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 36305-36318 | ||
| Property / Page(s): 36305-36318 / rank | |||
| + | Normal rank | ||
| Property / Fourth Author string | |||
| + | Jang MH | ||
| Property / Fourth Author string: Jang MH / rank | |||
| + | Normal rank | ||
| Property / Fifth Author string | |||
| + | Park SY | ||
| Property / Fifth Author string: Park SY / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Gwak JM, et al. Oncotarget (2017) cited as Ref 79 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Gwak JM
0 references
Kim M
0 references
Kim HJ
0 references
2017
0 references
Oncotarget
0 references
8
0 references
Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance (English)
0 references
36305-36318
0 references
Jang MH
0 references
Park SY
0 references
